
Cameron John Turtle MD
Instructor, Medicine, University of Washington School of Medicine
Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-228-1025
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 12 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cameron Turtle, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with UW Medicine/University of Washington Medical Center and is an Instructor at University of Washington School of Medicine.
Education & Training
- University of Sydney Faculty of MedicineClass of 1993
Certifications & Licensure
- WA State Medical License 2007 - 2022
Clinical Trials
- JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Start of enrollment: 2016 Nov 15
- huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia Start of enrollment: 2017 Nov 03
Publications & Presentations
PubMed
- Cytokine release syndrome and neurotoxicity following CD19 CAR-T in B-cell lymphoma.Roni Shouval, Christopher Strouse, Soyoung Kim, Temitope Oloyede, Sairah Ahmed
Transplantation and Cellular Therapy. 2025-04-25 - 1 citationsPhase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL.Jordan Gauthier, Emily C Liang, Jennifer J Huang, Erik L Kimble, Alexandre V Hirayama
Blood Advances. 2025-04-22 - Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.Fateeha Furqan, Kwang W Ahn, Manmeet Kaur, Jinalben Patel, Stephen Ansell
American Journal of Hematology. 2025-04-15
Press Mentions
- Patient and Family Experience with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) and Polyneuropathy (ATTR-PN) Amyloidosis: Results of Two Focus GroupsFebruary 8th, 2021
- Eureka Therapeutics Appoints Nobel Laureate Randy Schekman, Ph.D. To Its Scientific Advisory BoardNovember 9th, 2020
- Fred Hutch at ASH: Latest CAR T Data – BCMA, CD19, CD20 – plus New Insights on Transplantation, Gene Therapy – and MoreNovember 21st, 2019
- Join now to see all